EG017

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EG017, covering 2023-01-06 to 2023-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence [Phase 2]

See pricing